Format
Items per page
Sort by

Send to:

Choose Destination

Links from PubMed

Items: 1 to 20 of 157

1.

[Diagnostic investigation of the detection of granulocyte-macrophage colony stimulating factor antibody in serum for pulmonary alveolar proteinosis].

Li YQ, Chen YS, Li HR, Shang Y, Gao ZC.

Zhonghua Jie He He Hu Xi Za Zhi. 2013 May;36(5):351-6. Chinese.

PMID:
24047809
2.

[Autoantibody against granulocyte-macrophage colony-stimulating factor and other serum markers in pulmonary alveolar proteinosis].

Xu KF, Chen Y, Guo ZJ, Zhu YJ.

Zhonghua Jie He He Hu Xi Za Zhi. 2004 Dec;27(12):824-8. Chinese.

PMID:
15730782
3.

Standardized serum GM-CSF autoantibody testing for the routine clinical diagnosis of autoimmune pulmonary alveolar proteinosis.

Uchida K, Nakata K, Carey B, Chalk C, Suzuki T, Sakagami T, Koch DE, Stevens C, Inoue Y, Yamada Y, Trapnell BC.

J Immunol Methods. 2014 Jan 15;402(1-2):57-70. doi: 10.1016/j.jim.2013.11.011. Epub 2013 Nov 23.

PMID:
24275678
4.

Autoantibodies against granulocyte macrophage colony-stimulating factor are diagnostic for pulmonary alveolar proteinosis.

Bonfield TL, Russell D, Burgess S, Malur A, Kavuru MS, Thomassen MJ.

Am J Respir Cell Mol Biol. 2002 Oct;27(4):481-6.

PMID:
12356582
5.

High-affinity autoantibodies specifically eliminate granulocyte-macrophage colony-stimulating factor activity in the lungs of patients with idiopathic pulmonary alveolar proteinosis.

Uchida K, Nakata K, Trapnell BC, Terakawa T, Hamano E, Mikami A, Matsushita I, Seymour JF, Oh-Eda M, Ishige I, Eishi Y, Kitamura T, Yamada Y, Hanaoka K, Keicho N.

Blood. 2004 Feb 1;103(3):1089-98. Epub 2003 Sep 25.

6.

Multiplexed particle-based anti-granulocyte macrophage colony stimulating factor assay used as pulmonary diagnostic test.

Bonfield TL, John N, Barna BP, Kavuru MS, Thomassen MJ, Yen-Lieberman B.

Clin Diagn Lab Immunol. 2005 Jul;12(7):821-4.

7.

Detection of granulocyte-macrophage colony-stimulating factor in patients with pulmonary alveolar proteinosis.

Carraway MS, Ghio AJ, Carter JD, Piantadosi CA.

Am J Respir Crit Care Med. 2000 Apr;161(4 Pt 1):1294-9.

PMID:
10764326
8.

[Serum markers in patients with idiopathic pulmonary alveolar proteinosis].

Li Y, Tian X, Gui Y, Ma A, Li X, Zeng N, Zhang P, Li G, Xu K.

Zhonghua Jie He He Hu Xi Za Zhi. 2014 Jul;37(7):497-501. Chinese.

PMID:
25262689
9.

Clinical significance of anti-GM-CSF antibodies in idiopathic pulmonary alveolar proteinosis.

Lin FC, Chang GD, Chern MS, Chen YC, Chang SC.

Thorax. 2006 Jun;61(6):528-34. Epub 2006 Mar 3.

10.

Alveolar proteinosis syndrome: pathogenesis, diagnosis, and management.

Huizar I, Kavuru MS.

Curr Opin Pulm Med. 2009 Sep;15(5):491-8. doi: 10.1097/MCP.0b013e32832ea51c. Review.

PMID:
19561506
11.

Patient-derived granulocyte/macrophage colony-stimulating factor autoantibodies reproduce pulmonary alveolar proteinosis in nonhuman primates.

Sakagami T, Beck D, Uchida K, Suzuki T, Carey BC, Nakata K, Keller G, Wood RE, Wert SE, Ikegami M, Whitsett JA, Luisetti M, Davies S, Krischer JP, Brody A, Ryckman F, Trapnell BC.

Am J Respir Crit Care Med. 2010 Jul 1;182(1):49-61. doi: 10.1164/rccm.201001-0008OC. Epub 2010 Mar 11.

12.

Serum antibody against granulocyte/macrophage colony-stimulating factor and KL-6 in idiopathic pulmonary alveolar proteinosis.

Nara M, Sano K, Ogawa H, Tamada T, Nagaoka M, Okada K, Watanabe M, Moriya T, Miki H, Nakata K, Ichinose M, Hattori T.

Tohoku J Exp Med. 2006 Apr;208(4):349-54.

13.

Serological diagnosis of idiopathic pulmonary alveolar proteinosis.

Kitamura T, Uchida K, Tanaka N, Tsuchiya T, Watanabe J, Yamada Y, Hanaoka K, Seymour JF, Schoch OD, Doyle I, Inoue Y, Sakatani M, Kudoh S, Azuma A, Nukiwa T, Tomita T, Katagiri M, Fujita A, Kurashima A, Kanegasaki S, Nakata K.

Am J Respir Crit Care Med. 2000 Aug;162(2 Pt 1):658-62.

PMID:
10934102
14.

Serum neutralizing capacity of GM-CSF reflects disease severity in a patient with pulmonary alveolar proteinosis successfully treated with inhaled GM-CSF.

Arai T, Hamano E, Inoue Y, Ryushi T, Nukiwa T, Sakatani M, Nakata K.

Respir Med. 2004 Dec;98(12):1227-30.

PMID:
15588045
15.

Occupational inhalational exposure and serum GM-CSF autoantibody in pulmonary alveolar proteinosis.

Xiao YL, Xu KF, Li Y, Li Y, Li H, Shi B, Zhou KF, Zhou ZY, Cai HR.

Occup Environ Med. 2015 Jul;72(7):504-12. doi: 10.1136/oemed-2014-102407. Epub 2015 May 20.

PMID:
25995295
16.

Pulmonary alveolar proteinosis is a disease of decreased availability of GM-CSF rather than an intrinsic cellular defect.

Thomassen MJ, Yi T, Raychaudhuri B, Malur A, Kavuru MS.

Clin Immunol. 2000 May;95(2):85-92.

PMID:
10779401
17.

[pulmonary alveolar proteinosis and anti-GM-CSF antibody].

Watanabe M, Nakata K.

Nihon Naika Gakkai Zasshi. 2006 Jun 10;95(6):1042-7. Review. Japanese. No abstract available.

PMID:
16846053
18.
19.

Idiopathic pulmonary alveolar proteinosis as an autoimmune disease with neutralizing antibody against granulocyte/macrophage colony-stimulating factor.

Kitamura T, Tanaka N, Watanabe J, Uchida, Kanegasaki S, Yamada Y, Nakata K.

J Exp Med. 1999 Sep 20;190(6):875-80.

20.

Hereditary pulmonary alveolar proteinosis: pathogenesis, presentation, diagnosis, and therapy.

Suzuki T, Sakagami T, Young LR, Carey BC, Wood RE, Luisetti M, Wert SE, Rubin BK, Kevill K, Chalk C, Whitsett JA, Stevens C, Nogee LM, Campo I, Trapnell BC.

Am J Respir Crit Care Med. 2010 Nov 15;182(10):1292-304. doi: 10.1164/rccm.201002-0271OC. Epub 2010 Jul 9.

Format
Items per page
Sort by

Send to:

Choose Destination

Supplemental Content

Write to the Help Desk